CL Colgate-Palmolive Company
CL Colgate-Palmolive Company
Consumer Defensive · Household & Personal Products
Market read
POC $76.86 · VWAP $84.15 · +7.2% vs 12m avg buyer
Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)
Coverage
1 watchlist
CL Price Structure
Loading timeframes…
Peers
Every watchlist CL belongs to, members best 30-day change first — CL highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
Reported the quarter ending 2026-06-30: revenue $5.36B, diluted EPS $0.86, net income $693M (SEC filing). Across the print the stock moved -1.9% (close before → first close after).
full note →Against street estimates
How CL's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
News (last pull)
Headlines about CL from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 42 days ago · Jul 7
CL research tape
18 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.